- Home
- Publications
- Publication Search
- Publication Details
Title
Desmoglein-2 as a prognostic and biomarker in ovarian cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 21, Issue 12, Pages 1154-1162
Publisher
Informa UK Limited
Online
2020-11-21
DOI
10.1080/15384047.2020.1843323
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor
- (2020) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods
- (2020) Ruiying Sun et al. PeerJ
- Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma
- (2020) Runsen Jin et al. CANCER LETTERS
- Integrative prognostic subtype discovery in high‐grade serous ovarian cancer
- (2019) Hongyu Xie et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Junction opener protein increases nanoparticle accumulation in solid tumors
- (2018) Christine E. Wang et al. JOURNAL OF CONTROLLED RELEASE
- Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells
- (2017) Katharina Hütz et al. MOLECULAR CARCINOGENESIS
- Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells
- (2016) Kamola Saydaminova et al. CANCER BIOLOGY & THERAPY
- Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models
- (2016) Roma Yumul et al. HUMAN GENE THERAPY
- Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2
- (2016) Feng Cai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- 193. Preclinical and Clinical Data with a Fully Serotype 3 Oncolytic Adenovirus Ad3-hTERT-E1A in the Treatment of Advanced Solid Tumors
- (2016) MOLECULAR THERAPY
- Desmogleins as prognostic biomarkers in resected pancreatic ductal adenocarcinoma
- (2015) Steffen Ormanns et al. BRITISH JOURNAL OF CANCER
- Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1
- (2015) Hongjie Wang et al. JOURNAL OF VIROLOGY
- Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin
- (2015) Maximilian Richter et al. Molecular Therapy-Methods & Clinical Development
- Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells
- (2014) Wiebke K. Peitsch et al. PLoS One
- Characterization of Desmoglein Expression in the Normal Prostatic Gland. Desmoglein 2 Is an Independent Prognostic Factor for Aggressive Prostate Cancer
- (2014) Alison G. Barber et al. PLoS One
- A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
- (2013) Kenneth H. Kim et al. GYNECOLOGIC ONCOLOGY
- Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling
- (2013) R Kamekura et al. ONCOGENE
- Phenotypic and Transcriptional Fidelity of Patient-Derived Colon Cancer Xenografts in Immune-Deficient Mice
- (2013) Jeffrey Chou et al. PLoS One
- Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs
- (2012) I. Beyer et al. CLINICAL CANCER RESEARCH
- A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses
- (2012) H. Wang et al. JOURNAL OF VIROLOGY
- Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer
- (2011) I. Beyer et al. CANCER RESEARCH
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions
- (2011) H. Wang et al. JOURNAL OF VIROLOGY
- Analysis of Epithelial and Mesenchymal Markers in Ovarian Cancer Reveals Phenotypic Heterogeneity and Plasticity
- (2011) Robert Strauss et al. PLoS One
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- Increased expression of Dsg2 in malignant skin carcinomas
- (2010) Donna Brennan et al. Cell Adhesion & Migration
- Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses
- (2009) R. Strauss et al. CANCER RESEARCH
- Progress in Gynecologic Cancer
- (2009) Michael V. Seiden SEMINARS IN ONCOLOGY
- Physiology and Function of the Tight Junction
- (2009) J. M. Anderson et al. Cold Spring Harbor Perspectives in Biology
- Tight junctions as targets of infectious agents
- (2008) Julian A. Guttman et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
- (2008) Cynthia Kuk et al. MOLECULAR & CELLULAR PROTEOMICS
- EGFR and ADAMs Cooperate to Regulate Shedding and Endocytic Trafficking of the Desmosomal Cadherin Desmoglein 2
- (2008) Jodi L. Klessner et al. MOLECULAR BIOLOGY OF THE CELL
- Desmosome structure, composition and function
- (2007) David Garrod et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now